As of 2026-03-21, the Relative Valuation of Jazz Pharmaceuticals PLC (JAZZ) is 3.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 180.62 USD, the upside of Jazz Pharmaceuticals PLC based on Relative Valuation is -98.1%.
The range of the Relative Valuation is (71.95) - 133.74 USD.
| Range | Selected | |
| Trailing P/E multiples | 12.0x - 25.4x | 17.8x |
| Forward P/E multiples | 16.3x - 27.2x | 23.0x |
| Fair Price | (71.95) - 133.74 | 3.35 |
| Upside | -139.8% - -26.0% | -98.1% |
| Date | P/E |
| 2026-03-19 | -30.37 |
| 2026-03-18 | -30.15 |
| 2026-03-17 | -30.30 |
| 2026-03-16 | -30.41 |
| 2026-03-13 | -29.83 |
| 2026-03-12 | -30.12 |
| 2026-03-11 | -30.98 |
| 2026-03-10 | -31.06 |
| 2026-03-09 | -30.97 |
| 2026-03-06 | -30.41 |
| 2026-03-05 | -30.68 |
| 2026-03-04 | -31.52 |
| 2026-03-03 | -31.19 |
| 2026-03-02 | -31.82 |
| 2026-02-27 | -31.75 |
| 2026-02-26 | -31.57 |
| 2026-02-25 | -32.88 |
| 2026-02-24 | -29.04 |
| 2026-02-23 | -28.94 |
| 2026-02-20 | -28.77 |
| 2026-02-19 | -28.33 |
| 2026-02-18 | -28.19 |
| 2026-02-17 | -28.06 |
| 2026-02-13 | -27.78 |
| 2026-02-12 | -27.78 |
| 2026-02-11 | -27.77 |
| 2026-02-10 | -27.67 |
| 2026-02-09 | -27.57 |
| 2026-02-06 | -27.65 |
| 2026-02-05 | -27.26 |
| 2026-02-04 | -27.69 |
| 2026-02-03 | -27.87 |
| 2026-02-02 | -27.95 |
| 2026-01-30 | -27.48 |
| 2026-01-29 | -27.39 |
| 2026-01-28 | -27.63 |
| 2026-01-27 | -28.04 |
| 2026-01-26 | -27.79 |
| 2026-01-23 | -28.19 |
| 2026-01-22 | -28.57 |
| 2026-01-21 | -28.26 |
| 2026-01-20 | -28.05 |
| 2026-01-16 | -28.30 |
| 2026-01-15 | -28.59 |
| 2026-01-14 | -28.54 |
| 2026-01-13 | -27.14 |
| 2026-01-12 | -27.34 |
| 2026-01-09 | -26.92 |
| 2026-01-08 | -26.77 |
| 2026-01-07 | -28.30 |